DOCTOR STRANGE #177

Cover shows good gloss retention and bright colors with no major creases visible. There is some wear at the top and bottom of the spine with minor whitening/stress lines, slight corner blunting at the top right, and a small amount of edge wear along the right border. The book is in a protective sleeve, which limits full assessment of surface sheen; interior and back cover were not examined.

Doctor Strange #177 arrived in early 1969 during the closing chapters of the character's original ongoing title, a series that had struggled commercially since its launch and would be cancelled within the year. The book falls within the Roy Thomas-scripted, Gene Colan-illustrated stretch of the run, a pairing generally regarded as the artistic high point of the Silver Age Doctor Strange stories, with Colan's fluid, shadow-heavy linework well suited to the character's mystical milieu. The issue does not carry a recognized first appearance, origin, or landmark creative event; its interest rests on being a representative chapter of a short, tightly collected series rather than on any single historic moment.

Market activity mirrors that profile. Sales are frequent through the mid grades, reflecting a modestly sized but actively traded population, with pricing climbing gradually from the teens and twenties in low grade up through the double digits and low hundreds by grade 9.2. A sharp jump appears at 9.4, where thin high-grade supply pushes fair value well above the 9.2 tier, and the complete absence of certified 9.6 or 9.8 copies signals that any book reaching those tiers would be effectively unprecedented on the open market. Demand is driven primarily by Doctor Strange completists and Gene Colan admirers assembling the full run of the 1968-1969 series rather than by speculative key-issue buying.

For collectors, this is a steady mid-run Silver Age acquisition: affordable in low and mid grade, where most transactions occur, and disproportionately expensive only at the extreme top of the grading scale where population data all but disappears. It suits Doctor Strange series collectors and Colan-era art buyers more than investors chasing character milestones, and pricing across grades should be expected to track general Silver Age Marvel demand rather than move independently on news or nostalgia cycles.